GYRE - GYRE THERAPEUTICS, INC.

8.28
0.380   4.589%

Share volume: 100,514
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$7.90
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-13-2024 08-13-2024 11-13-2024 03-17-2025 05-09-2025 08-11-2025 11-07-2025
Cash flow financing 658.000 K 156.000 K 324.000 K 964.000 K 1.344 M 22.351 M 365.000 K
Other financing cash flows 658.000 K 275.000 K 374.000 K 22.000 K 956.000 K 1.032 M 50.000 K
Cash flow -3.678 M -13.610 M -337.000 K -3.798 M 3.182 M 21.397 M 3.794 M
Net income 9.935 M 4.538 M 2.856 M 569.000 K 3.734 M 1.576 M 5.936 M
Depreciation 415.000 K 228.000 K 445.000 K 461.000 K 535.000 K 641.000 K 649.000 K
Changes in inventories 666.000 K 0.000 0.000 0.000 1.541 M 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -7.220 M -8.273 M -2.387 M -2.004 M 1.967 M -3.042 M -1.247 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other -7.039 M -7.035 M -1.686 M 289.000 K -8.403 M -2.781 M 0.000
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 181.000 K 1.238 M 698.000 K -203.000 K 121.000 K 238.000 K 668.000 K
Cash Change -3.724 M -13.688 M -231.000 K -4.053 M 3.232 M 21.446 M 3.911 M